Published in Neuroimage on March 11, 2011
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Random forest-based similarity measures for multi-modal classification of Alzheimer's disease. Neuroimage (2012) 1.71
Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome. Dev Med Child Neurol (2013) 1.61
Classification and lateralization of temporal lobe epilepsies with and without hippocampal atrophy based on whole-brain automatic MRI segmentation. PLoS One (2012) 1.27
Multi-atlas segmentation of biomedical images: A survey. Med Image Anal (2015) 1.17
Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease. Neuroimage (2012) 1.00
A robust method for investigating thalamic white matter tracts after traumatic brain injury. Neuroimage (2012) 0.95
Multimodal neuroimaging feature learning for multiclass diagnosis of Alzheimer's disease. IEEE Trans Biomed Eng (2014) 0.94
Magnetization-prepared rapid acquisition with gradient echo magnetic resonance imaging signal and texture features for the prediction of mild cognitive impairment to Alzheimer's disease progression. J Med Imaging (Bellingham) (2014) 0.86
Multifold Bayesian kernelization in Alzheimer's diagnosis. Med Image Comput Comput Assist Interv (2013) 0.84
Multi-Channel neurodegenerative pattern analysis and its application in Alzheimer's disease characterization. Comput Med Imaging Graph (2014) 0.82
A practical guideline for intracranial volume estimation in patients with Alzheimer's disease. BMC Bioinformatics (2015) 0.81
Multimodal neuroimaging computing: the workflows, methods, and platforms. Brain Inform (2015) 0.80
Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP. Neuroimage (2014) 0.79
Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory. Mol Psychiatry (2016) 0.78
Localized Sparse Code Gradient in Alzheimer's disease staging. Conf Proc IEEE Eng Med Biol Soc (2013) 0.78
Neuroanatomical Correlates of Recognizing Face Expressions in Mild Stages of Alzheimer's Disease. PLoS One (2015) 0.77
An efficient approach for differentiating Alzheimer's disease from normal elderly based on multicenter MRI using gray-level invariant features. PLoS One (2014) 0.76
Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease Staging. Front Aging Neurosci (2016) 0.75
Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease. Front Aging Neurosci (2016) 0.75
Repeatability, Reproducibility, Separative Power and Subjectivity of Different Fish Morphometric Analysis Methods. PLoS One (2016) 0.75
Description and classification of normal and pathological aging processes based on brain magnetic resonance imaging morphology measures. J Med Imaging (Bellingham) (2014) 0.75
Manual-Protocol Inspired Technique for Improving Automated MR Image Segmentation during Label Fusion. Front Neurosci (2016) 0.75
Dictionary Pruning with Visual Word Significance for Medical Image Retrieval. Neurocomputing (2015) 0.75
Pairwise Latent Semantic Association for Similarity Computation in Medical Imaging. IEEE Trans Biomed Eng (2015) 0.75
Gyri of the human parietal lobe: Volumes, spatial extents, automatic labelling, and probabilistic atlases. PLoS One (2017) 0.75
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging (1998) 23.54
Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging (1999) 21.56
Automatically parcellating the human cerebral cortex. Cereb Cortex (2004) 18.32
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68
Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal (2007) 13.54
Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage (2009) 11.90
A Population-Average, Landmark- and Surface-based (PALS) atlas of human cerebral cortex. Neuroimage (2005) 9.74
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50
Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage (2005) 8.50
Automatic anatomical brain MRI segmentation combining label propagation and decision fusion. Neuroimage (2006) 8.15
A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm (1987) 8.01
Construction of a 3D probabilistic atlas of human cortical structures. Neuroimage (2007) 7.04
Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71
A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage (2010) 6.24
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Multi-atlas based segmentation of brain images: atlas selection and its effect on accuracy. Neuroimage (2009) 5.16
Evaluation of atlas selection strategies for atlas-based image segmentation with application to confocal microscopy images of bee brains. Neuroimage (2004) 4.76
Combination strategies in multi-atlas image segmentation: application to brain MR data. IEEE Trans Med Imaging (2009) 4.44
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp (2003) 4.34
Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology (1992) 3.87
Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol (2001) 3.43
Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. J Magn Reson Imaging (2002) 3.34
Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans. J Neurosci Methods (2005) 3.32
Fast free-form deformation using graphics processing units. Comput Methods Programs Biomed (2009) 3.18
Fast and robust multi-atlas segmentation of brain magnetic resonance images. Neuroimage (2009) 3.13
Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed (1997) 2.56
Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol (1991) 2.41
Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke (2008) 2.21
Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest. Neuroimage (2007) 2.13
LEAP: learning embeddings for atlas propagation. Neuroimage (2009) 2.09
Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain (2008) 2.02
Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies. Hippocampus (2009) 1.95
FreeSurfer-initiated fully-automated subcortical brain segmentation in MRI using Large Deformation Diffeomorphic Metric Mapping. Neuroimage (2008) 1.95
Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol (2001) 1.94
Human cerebral cortex: localization, parcellation, and morphometry with magnetic resonance imaging. J Cogn Neurosci (1992) 1.91
Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol (1994) 1.81
Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex (1998) 1.70
Hippocampus segmentation in MR images using atlas registration, voxel classification, and graph cuts. Neuroimage (2008) 1.69
Improving intersubject image registration using tissue-class information benefits robustness and accuracy of multi-atlas based anatomical segmentation. Neuroimage (2010) 1.65
Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology (2008) 1.64
Mindboggle: a scatterbrained approach to automate brain labeling. Neuroimage (2004) 1.64
Methods for normalization of hippocampal volumes measured with MR. AJNR Am J Neuroradiol (1995) 1.64
Computational anatomy and neuropsychiatric disease: probabilistic assessment of variation and statistical inference of group difference, hemispheric asymmetry, and time-dependent change. Neuroimage (2004) 1.64
MRI-based automated computer classification of probable AD versus normal controls. IEEE Trans Med Imaging (2008) 1.58
Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage (2009) 1.53
Automatic detection and quantification of hippocampal atrophy on MRI in temporal lobe epilepsy: a proof-of-principle study. Neuroimage (2007) 1.48
Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI. Neuroimage (2010) 1.46
Asymmetry of the hippocampus and amygdala in MRI volumetric measurements of normal adults. J Int Neuropsychol Soc (2004) 1.46
Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol (2006) 1.35
Segmentation of image ensembles via latent atlases. Med Image Anal (2010) 1.33
Direct mapping of hippocampal surfaces with intrinsic shape context. Neuroimage (2007) 1.29
Mindboggle: automated brain labeling with multiple atlases. BMC Med Imaging (2005) 1.28
Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging (2001) 1.27
Combining shape and connectivity analysis: an MRI study of thalamic degeneration in Alzheimer's disease. Neuroimage (2009) 1.26
Computational cardiac anatomy using MRI. Magn Reson Med (2004) 1.23
A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T). Neuroimage (2010) 1.23
Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch Neurol (2005) 1.22
Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol (1993) 1.15
Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction. Neurology (1991) 1.13
Asymmetry of pathology in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1987) 1.13
The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia. Neurobiol Aging (2002) 1.11
Magnetic resonance imaging-based brain morphometry: development and application to normal subjects. Ann Neurol (1989) 1.11
A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord (2001) 1.05
Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dement Geriatr Cogn Disord (2005) 1.04
Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients. J Alzheimers Dis (2010) 1.00
Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience (1990) 1.00
Reproducibility of thalamic segmentation based on probabilistic tractography. Neuroimage (2010) 0.98
A volumetric magnetic resonance imaging study of the amygdala in frontotemporal lobar degeneration and Alzheimer's disease. Dement Geriatr Cogn Disord (2005) 0.92
Automatic volumetry on MR brain images can support diagnostic decision making. BMC Med Imaging (2008) 0.87
Magnetic resonance analysis of amygdalar volume in Alzheimer's disease. Curr Opin Psychiatry (2007) 0.87
Neuropathological asymmetry in argyrophilic grain disease. J Neuropathol Exp Neurol (2010) 0.87
Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer's disease. Arch Neurol (1989) 0.84
Asymmetry of pathology in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1988) 0.81
Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage (2006) 23.57
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol (2009) 14.42
Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage (2009) 11.90
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Automatic anatomical brain MRI segmentation combining label propagation and decision fusion. Neuroimage (2006) 8.15
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol (2010) 5.53
Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage (2011) 5.24
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain (2009) 4.51
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage (2010) 4.28
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage (2007) 4.07
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging (2009) 3.97
The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement (2010) 3.85
Diffusion-weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality. Pediatrics (2003) 3.80
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology (2012) 3.58
Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease. Neuroimage (2011) 3.47
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement (2010) 3.30
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage (2010) 3.27
Fast and robust multi-atlas segmentation of brain magnetic resonance images. Neuroimage (2009) 3.13
Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement (2010) 3.11
Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol (2012) 3.03
Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc (2007) 3.00
Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology (2009) 2.90
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One (2009) 2.85
Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol (2012) 2.84
Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol (2011) 2.83
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage (2009) 2.80
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
Voxelwise genome-wide association study (vGWAS). Neuroimage (2010) 2.69
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement (2010) 2.68
Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain (2009) 2.61
Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am J Neuroradiol (2010) 2.61
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis (2005) 2.59
Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain (2009) 2.51
Longitudinal change of biomarkers in cognitive decline. Arch Neurol (2011) 2.51
Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates. Neuroimage (2011) 2.50
Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset. Neuroimage (2009) 2.47
Automatic quality assessment in structural brain magnetic resonance imaging. Magn Reson Med (2009) 2.43
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol (2011) 2.41
Automatic segmentation and reconstruction of the cortex from neonatal MRI. Neuroimage (2007) 2.41
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 2.37
Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage (2010) 2.32
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging (2008) 2.31
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain (2008) 2.28
Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage (2009) 2.28
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach. Neuroimage (2010) 2.27
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis (2008) 2.27
Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T--feasibility. Radiology (2008) 2.25
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp (2009) 2.24
Diffeomorphic registration using B-splines. Med Image Comput Comput Assist Interv (2006) 2.23
Automatic construction of multiple-object three-dimensional statistical shape models: application to cardiac modeling. IEEE Trans Med Imaging (2002) 2.23
Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: an illustration in ADNI 3 T MRI data. Neuroimage (2009) 2.22
Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology (2010) 2.20
Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology (2009) 2.18
CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J Neurosci (2010) 2.18
Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol (2010) 2.16
A dynamic 4D probabilistic atlas of the developing brain. Neuroimage (2010) 2.14
Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging (2010) 2.13
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12
Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models. Neuroimage (2012) 2.11
Validation study of the accuracy of echocardiographic measurements of systemic blood flow volume in newborn infants. J Am Soc Echocardiogr (2013) 2.11
LEAP: learning embeddings for atlas propagation. Neuroimage (2009) 2.09
The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. Alzheimers Dement (2010) 2.09
MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology (2011) 2.08
Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain (2013) 2.05
Progressive neocortical damage in epilepsy. Ann Neurol (2003) 2.04
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03
Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology (2014) 2.03
MRI of moving subjects using multislice snapshot images with volume reconstruction (SVR): application to fetal, neonatal, and adult brain studies. IEEE Trans Med Imaging (2007) 2.03
Diffusion tensor imaging with tract-based spatial statistics reveals local white matter abnormalities in preterm infants. Neuroimage (2007) 2.02